PET Imaging in Patients With Suspected Cardiac Sarcoidosis

CompletedOBSERVATIONAL
Enrollment

20

Participants

Timeline

Start Date

December 1, 2018

Primary Completion Date

December 1, 2022

Study Completion Date

December 1, 2022

Conditions
Cardiac Sarcoidosis
Interventions
DRUG

Gallium-68 DOTATATE

Gallium-68 DOTATATE is a radioactive tracer, a type of imaging drug that is labeled with a radioactive tag and injected into the body, which is approved by the U.S. Food and Drug Administration (FDA) to diagnose certain tumors.

Trial Locations (1)

19104

University of Pennsylvania, Philadelphia

Sponsors
All Listed Sponsors
collaborator

Advanced Accelerator Applications

INDUSTRY

lead

University of Pennsylvania

OTHER